Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Similar Posts
Cambridge lab grows 'mini-placentas' for pre-eclampsia study
Pre-eclampsia affects millions of women worldwide yet is little understood, say scientists.
Is it okay to touch a pregnant woman’s belly? Experts and moms weigh in
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
These 8 health screenings should be on your calendar for 2024, according to doctors
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Doctor uses Apple Watch to help Ryanair passenger
A doctor used an Apple Watch to aid an elderly woman who suffered a medical emergency on a flight. NHS doctor Rashid Riaz, from Hereford, was travelling by Ryanair from Birmingham to Verona for a skiing holiday. During the journey on 9 January, the woman, in her 70s, experienced shortness of breath, with the cabin…
We like health-care stocks in 2024 despite presidential election year weakness
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector…
Moderna Covid vaccine sales plunge in 2023, but meet company forecast
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…